Reduction of immunoglobulin levels during imatinib therapy of chronic myeloid leukemia

Leuk Res. 2008 Jan;32(1):191-2. doi: 10.1016/j.leukres.2007.02.013. Epub 2007 Mar 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Agammaglobulinemia / chemically induced*
  • Agammaglobulinemia / complications
  • Benzamides
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Male
  • Piperazines / adverse effects*
  • Pyrimidines / adverse effects*

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate